Navigation Links
Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
Date:3/7/2008

BERKELEY HEIGHTS, N.J., March 7 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today the Company has entered into an exclusive worldwide licensing agreement with Daiichi Sankyo Company, Limited (TYO: 4568) for the development and commercialization of tesetaxel (formerly known as DJ-927). As a late Phase 2 oncology product, tesetaxel has demonstrated anticancer activity in its initial clinical trials, and the drug has not been associated with the severe infusion reactions that are linked with other taxanes, such as paclitaxel (Taxol(R)) and docetaxel (Taxotere(R); sanofi aventis). Moreover, unlike other oral taxanes that are currently in clinical development, nerve damage has not been a prominent side effect of tesetaxel. Preclinical studies also show that tesetaxel does not share resistance mechanisms that are associated with other taxanes. Thus, the drug offers substantial opportunities to improve patient convenience, safety, and anticancer activity.

Under terms of the agreement, Daiichi Sankyo will receive upfront payments, payments pursuant to the achievement of certain milestones, and royalties on product sales.

"Tesetaxel has demonstrated promising antitumor activity with an acceptable safety profile that offers potential use in a variety of cancer types," commented Dr. Anthony W. Tolcher, Clinical Director of South Texas Accelerated Research Therapeutics (START) in San Antonio, TX. "As someone who tested this product and other oral taxanes over the past several years, I am distinctly pleased to see it return to active clinical development."

More than 250 patients worldwide have been treated with oral tesetaxel in Phase I and Phase 2 clinical trials. The major side-effect of tesetaxel in cl
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
2. Genta to Present at Bio Investor Forum 2007 Conference
3. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
4. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
5. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
6. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
7. Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
8. ACS Announces $57 Million Contract With Missouri HealthNet
9. Nfocus Neuromedical Announces Acquisition of StarFire Medical
10. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
11. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Horizon NJ Health, New Jersey’s largest ... it has earned a Commendable Accreditation status from ... Health is a wholly owned subsidiary of Horizon Blue ... Health Plan Accreditation is a nationally recognized program that ... plans provide to their members. Health Plan Accreditation performance ...
(Date:5/20/2013)... Science is proud to announce the publication of the ... Robert A. Weinberg. , The First Edition has ... incorporating the most important advances in the fast-growing field ... maintains all of its hallmark features admired by students, ... Biology of Cancer is a textbook for students studying ...
(Date:5/20/2013)... (HealthDay News) -- Although many hospital intensive care ... to help improve outcomes, new research suggests this ... Since one-third of teaching hospitals in the United ... a nighttime physician in the ICU, the practice ... away from hospitals with fewer resources, the study ...
(Date:5/20/2013)... departments play a growing role in the U.S. health ... admissions and serving increasingly as an advanced diagnostic center ... Corporation study. , While often targeted as the most ... an important safety net for Americans who cannot get ... the growth of health care costs, according to the ...
(Date:5/20/2013)... Nearly three out of four pregnant women experience ... a Loyola University Medical Center study has found. , ... pregnant women,s quality of life, the study found. , ... Payton Johnson was presented during the American Congress of ... Orleans. , One hundred and four pregnant women were ...
Breaking Medicine News(10 mins):Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3Health News:'The Biology of Cancer' by Robert A. Weinberg 2Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
... being issued by Foundation for Taxpayer and Consumer Rights:, ... against proposed legislation that,would create a loophole in existing ... a patient,s consent. The bill, SB 1096,(Calderon), does so ... to provide health care services. Transfers of private medical,information ...
... PLYMOUTH MEETING, Pa., March 12 Four,Rivers Software ... (CMMS) for the healthcare industry and ECRI Institute,an ... improving,patient care, announce the availability of new, real-time ... alert applications., This new integration offers ...
... 12 Managed Health Care,Associates, Inc. (MHA) announces ... Member Study, the results of which will be,revealed ... 2008 in Las Vegas,Nevada., The report was ... 2007,and examined self-reported data for key operational elements ...
... , Researchers from EPFL and Caltech have made an ... The research, appearing in the March 12 issue of ... kinds of risk, notably financial risk, are often underestimated, and ... drugs) could be caused by an erroneous evaluation of risk. ...
... Hospital today announced the start of the EASE (Exhale ... trial to explore an investigational treatment that may offer ... emphysema. The study focuses on a new procedure, called ... for trapped air (one of the primary causes of ...
... of,positive tests for methamphetamine among U.S. job applicants and ... percent between 2006 and,2007. These findings, from the Quest ... trend in use of the drug by more than ... today by Quest,Diagnostics Incorporated (NYSE: DGX ), the ...
Cached Medicine News:Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 2Health News:Four Rivers Software Systems and ECRI Institute Announce New, Real-Time Interfaces to Improve Inventory Management and Patient Safety Alert and Recall Tracking 3Health News:MHA to Release Findings of Independent Long Term Care Member Study 2Health News:To bet or not to bet: How the brain learns to estimate risk 2Health News:Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers 2Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 2Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 3Health News:Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics 4
(Date:5/17/2013)...  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... UBS Global Healthcare Conference in New York ... at 11 a.m. Eastern Time. To listen to the ... the Investor Relations section of the Company,s Web site at ... days after the event. About Orexigen® Therapeutics ...
(Date:5/17/2013)... 2013   Shareholder rights attorneys  at Robbins Arroyo ... (NASDAQGS: AVEO) securities has filed a complaint in the ... Massachusetts .  The complaint alleges that Aveo and ... of 1934 (the "Exchange Act") between January 3, 2012 ... (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) Aveo ...
(Date:5/17/2013)... CHAMPAIGN, Ill. , May 17, 2013  Sony ... new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be ... 2013, which will be held at the ... San Diego, California , from May 20 - ... Sony,s second analytical system, incorporating commercial audio-visual technologies into ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Nov. 28, 2011 Abbott (NYSE: ABT) announced today that ... S.A. (GSK) to include the development of an additional ... research program. Companion diagnostic tests are designed to identify ... which patients are more or less likely to benefit ...
... Medical Systems, Inc., a developer of premium ultrasound ... abdominal ultrasound imaging solutions for diverse patient populations ... the Radiology Society of North America, November 27 ... system delivers high-end image quality powered by its ...
Cached Medicine Technology:Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen 2Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen 3ZONARE Medical Systems to Showcase z.one Ultrasound Platform at RSNA 2ZONARE Medical Systems to Showcase z.one Ultrasound Platform at RSNA 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: